Sensus Healthcare, Inc. (SRTS) saw a 2.26% increase in its stock price, outperforming the S&P 500. However, the stock has fallen by 8.55% in the last month, underperforming the Medical sector. The upcoming earnings release is anticipated to show a significant decrease in EPS and revenue compared to the previous year.

Analysts have adjusted their estimates for Sensus Healthcare, Inc., prompting a Zacks Rank of #5 (Strong Sell). The Medical – Instruments industry, part of the Medical sector, has a Zacks Industry Rank of 90, indicating it is in the top 37% of all industries. Investors should monitor these metrics closely for potential impacts on stock performance.

Zacks experts have identified 5 stocks with the potential to double in value, including companies in disruptive industries and poised for growth. Previous recommendations have seen significant gains, making these picks worth considering for investors looking for high-return opportunities in the market. Download the free report today for more insights.

Read more at Nasdaq: Sensus Healthcare, Inc. (SRTS) Surpasses Market Returns: Some Facts Worth Knowing